EXHIBIT 99.1 Wilmington, Del., November 4, 2024 – The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global leader in delivering innovative performance chemistry through Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced its financial results for the third quarter 2024 and provided an update on the Company's corporate strategy. Key Third Quarter 2024 Results & Highlights • Net Sales of $1.5 billion, in line with th ...

Chemours (CC) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on November 4, 2024, might help the stock move higher if these key numbers are better than exp ...

The Chemours Company (CC) has announced that it is developing a low global warming potential (GWP) refrigerant retrofit strategy for the automotive aftermarket to help support the global phaseout of higher GWP hydrofluorocarbon (HFC) refrigerants. The technical approach will allow car owners and service professionals with a simple retrofit process to safely and cost-effectively replace the legacy R-134a refrigerant in their existing vehicle with the widely used, low GWP Opteon YF refrigerant. Opteon YF was ...

JHVEPhoto Dear readers/followers, When I last covered Chemours (NYSE:CC) the company had seen some irregularities in its operations in accounting. In my last article, I saw a positive rate of return for the investment I made a few months prior - and the current rate of return from that article is barely negative here - but since my last piece, the stock is actually down a bit over 10%. In this article, we'll look at the longer-term implications and background of this move. I've long owned Chemours, unfortun ...

The Chemours Company (CC) recently announced the opening of the Chemours Battery Innovation Center (CBIC), a state-of-the-art laboratory facility located at the Chemours Discovery Hub in Newark, DE. This multi-million-dollar investment aims to support the testing and scaling of next-generation battery technologies, ultimately enabling more sustainable, cost-effective, energy-efficient and high-performing batteries for hybrid and electric vehicles (EVs). Chemours, which is among prominent players in the chem ...

NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company ("Chemours" or "the Company") (NYSE: CC). Investors who purchased Chemours securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CC. Investigation Details On August 1, 2024, Chemours reported its financial results for the second quarter of 2024. The Com ...

The Chemours Company (NYSE:CC) Q2 2024 Earnings Conference Call August 2, 2024 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - SVP, CFO & Principal Accounting Officer Conference Call Participants John McNulty - BMO Capital Markets Mike Leithead - Barclays John Roberts - Mizuho Josh Spector - UBS Financial Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies Arun Viswanathan - RBC Capital Markets Vincent Andrews - Morgan Stanley J ...

Second Quarter 2024 Earnings Presentation August 1, 2024 Safe Harbor Statement and Other Matters 2 We prepare our financial statements in accordance with Generally Accepted Accounting Principles (GAAP). Within this press release, we may make reference to Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, Total Debt Principal, Net and Net Leverage Ratio which are non-GAAP financial measures. The Company includes these non-GAAP financial measures because management believes they are useful to investors in th ...

For the quarter ended June 2024, Chemours (CC) reported revenue of $1.54 billion, down 6.4% over the same period last year. EPS came in at $0.38, compared to $1.10 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.54 billion, representing a surprise of +0.01%. The company delivered an EPS surprise of -42.42%, with the consensus EPS estimate being $0.66. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expe ...

Chemours (CC) came out with quarterly earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $1.10 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -42.42%. A quarter ago, it was expected that this chemical company would post earnings of $0.25 per share when it actually produced earnings of $0.32, delivering a surprise of 28%. Over the last four quarters, the company h ...